US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 4.290
  • +0.020+0.47%
Close May 9 16:00 ET
  • 4.000
  • -0.290-6.76%
Post 19:49 ET
447.08MMarket Cap-1120P/E (TTM)

Revance Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Apr 30, 2024

Based on 9 analysts giving stock ratings to Revance Therapeutics in the past 3 months

Strong Buy

  • Buy

    77.78%

  • Hold

    22.22%

  • Sell

    0.00%

Price Target

Updated: Apr 30, 2024

The average Revance Therapeutics stock price target is 16.56 with a max estimate of 30.00 and a min estimate of 9.00

Review Revance Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    77.78%

  • Hold

    22.22%

  • Sell

    0.00%

Price Target

Updated: Apr 30, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg